共表达KnobS蛋白与LTB蛋白的重组干酪乳杆菌构建

在干酪乳杆菌中表达减蛋综合征病毒纤维蛋白KnobS,并分析其抗原性。分别将编码减蛋综合征病毒主要免疫保护性抗原纤维蛋白KnobS与大肠杆菌不耐热肠毒素B亚单位(LTB)基因插入干酪乳酸杆菌分泌表达载体pMG36e-UP/L中,成功构建重组表达载体pMG36e-UP/LTB-KnobS,获得表达融合蛋白KnobS-LTB的重组乳酸菌干酪乳杆菌表达系统;经SDS-PAGE和Western-blot检测表明,有大小约41kD的蛋白表达,具有与天然病毒蛋白一样的抗原特异性。在干酪乳杆菌中成功地表达了含减蛋综合征病毒抗原的融合蛋白KnobS-LTB,且具有较好的抗原性,为减蛋综合征病毒重组乳酸菌活菌口服疫苗的研制奠定重要的物质基础。     

黑曲霉F246的phyA基因克隆及其新型表达载体构建

利用PCR法直接从自行筛选、鉴定的黑曲霉F246中扩增出phyA基因,再将PCR产物重组于乳酸菌表达载体pMG36e,构建phyA基因的新型表达载体pMG36e-phyA.以黑曲霉F246基因组为模板,对phyA基因的成熟肽(1 347 bp)进行PCR扩增.再将PCR产物克隆入pMD18T质粒,经DNA测序和氨基酸分析、鉴定正确后,亚克隆入乳酸菌表达质粒pMG36e,构建工程菌Lactobacillus MG1363-pMG36e-phyA.重组乳酸菌表达载体pMG36e-phyA的构建,可望获得大量、高活性植酸酶,为研制多功能微生态制剂奠定基础.     

干酪乳杆菌同源整合载体的构建与鉴定

构建乳酸菌同源重组载体,以实现外源基因在乳酸菌中的整合型表达。PCR扩增lacZ基因表达盒lacZ-cassette,和upp基因表达盒upp-cassette,SOE-PCR扩增lacZ-P-upp,产物回收后连接到pORI28载体中,构建载体pORZP;根据干酪乳杆菌Lactobacillus casei 393全基因组中lai基因序列设计引物,PCR扩增lai基因两端同源重组臂lai-up和lai-down基因序列,产物经回收后,连接至pORZP载体中,得同源重组载体pORZPlai。双酶切及DNA测序结果证实,成功构建了同源重组载体pORZP-lai,为实现外源基因在乳酸菌中的非抗性、整合型表达奠定了基础。     

Paenibacillus sp. K1 乳糖酶基因bga在乳酸乳球菌中的表达

为了提高乳酸乳球菌利用乳糖的能力,缓解乳糖不耐症,以实验室构建的含有乳糖酶基因的质粒pUC-bga为模板,通过PCR扩增得到乳糖酶基因bga,将其分别与载体pSEC和pMG36e连接,获得重组质粒pSEC-bga和pMG36e-bga,重组质粒分别电转Lactococcus lactis NZ9000和Lactococcus lactis MG1614,并在乳酸乳球菌细胞内实现了活性表达。高压液相色谱（HPLC）分析其对培养基中乳糖的利用能力,结果重组菌L.lactis NZ9000-Bga对乳糖的利用能力比对照菌株高一倍,为生产低乳糖的发酵乳制品奠定了基础。     

干酪乳杆菌IMAU10041抗甜瓜枯萎病菌的作用及理化性质

从60株乳酸菌中筛选出22株具有抗甜瓜枯萎病菌活性的乳酸菌菌株,其中9株具有较强抗甜瓜枯萎病菌活性.对这9株乳酸菌的抗植物致病真菌谱进行研究发现,9株菌对番茄早疫病菌(Alternaria solani)、甜瓜疫霉菌(Phytophthora drechsleri Tucker)、苹果炭疽病菌(Glomerella cingulate)、灰葡萄孢霉菌(Botrytis cinerea)的生长均有抑制作用.其中干酪乳杆菌IMAU10041对甜瓜枯萎病菌具有较强的抑制作用,并且对甜瓜疫霉和番茄早疫病菌有较高的抑菌活性.分别经过调节pH、加热、蛋白酶处理干酪乳杆菌IMAU10041的发酵滤液后,发现干酪乳杆菌IMAU10041发酵液具有一定的热稳定性;在pH 4.0时具有最大抑菌活性,在碱性条件下抑菌活性迅速失活;发酵液经胰蛋白酶、中性蛋白、蛋白酶K处理后失去部分抑菌活性,这表明干酪乳杆菌IMAU10041发酵液中可能含有一定的蛋白类抑菌物质.     

植物乳杆菌Lactobacillu plantarumY1菌株胆盐水解酶基因(bsh)的克隆及重组表达

经同源蛋白比对分析设计引物,PCR 扩增获得植物乳杆菌Y1菌株bsh基因(975bp),首先克隆至表达载体pET-28a,转化E. coli BL21(DE3)菌株,IPTG 诱导表达,SDS-PAGE分析结果显示表达的重组蛋白为包涵体.选择能为大肠杆菌稀有密码子提供额外tRNA 的E. coli Rosetta(DE3)作为宿主菌,仍旧没有改善表达产物的可溶性.但是,选择含IF2融合蛋白标签的pLS-IF2质粒构建表达载体,SDS-PAGE分析及Western blot 鉴定结果显示表达的融合重组蛋白IF2-BSH具有可溶性.该结果为进一步研究乳酸菌胆盐水解酶的生物活性,结构功能关系的研究奠定了基础.     

藏鸡源乳酸菌的筛选鉴定及IBV N基因的表达研究

从藏鸡(海拔3000米藏区、自然放养、未使用过抗生素)肠道内筛选乳杆菌, 经16s rDNA和生理生化试验鉴定为植物乳杆菌.通过耐酸耐胆汁试验和肠道黏附试验测试, 表明其具有良好的耐酸耐胆汁能力和肠道黏附能力.为使外源质粒顺利转化入乳杆菌, 进行电场强度的优化, 再按照优化后的电场强度, 将禽冠状病毒pSIP409 N重组质粒电转化入该株乳杆菌, 进行双酶切和PCR鉴定.将经鉴定成功转入的重组乳杆菌, 用诱导肽SppIP诱导表达, 再进行SDS PAGE检测外源蛋白的表达.结果表明N蛋白能够顺利表达. 上述试验证明该株植物乳杆菌具有作为乳酸菌活载体疫苗的潜力.     

LTB的表达及其粘膜免疫佐剂活性分析

粘膜免疫是预防一些通过吸附粘膜组织侵入机体病原的很好措施,但粘膜免疫通常需要粘膜免疫佐剂,大肠杆菌(Escherichia coli)不耐热肠毒素的B亚基具有很好的粘膜免疫佐剂活性.本研究从大肠杆菌195菌株中扩增出LT(heat-labile enterotoxin)基因,测序后将其B亚基基因与pET32a连接构建了重组质粒pET32a-LTB,SDS-PAGE显示LTB(heat-labile enterotoxin B subunit)在原核细胞中得到表达,Western blotting和人神经节苷脂结合酶联免疫吸附试验(GM1-ELISA)结果表明,重组LTB具有抗原性和GM1结合活性.将其与禽流感M2e表位融合蛋白M2eHBc+混合通过滴鼻途径免疫小鼠,抗体检测结果表明,所表达的LTB能很好地提高共免疫抗原的粘膜和系统免疫应答.     

两种乳酸菌胞外多糖抑制胃癌细胞的生长比较研究

采用MTT比色法,比较干酪乳杆菌和嗜酸乳杆菌胞外多糖对胃癌细胞823生长的抑制作用,以评价两种菌株所产胞外多糖的抗肿瘤活性.结果表明,两种胞外多糖对胃癌细胞823生长均有一定的抑制活性,其中干酪乳杆菌胞外多糖抑制效果更显著,这将为开发以乳酸菌为代表的益生菌新的产品提供依据.     

苏云金芽孢杆菌aiiA基因在毕赤酵母中的分泌表达

根据GenBank中aiiA基因设计引物,以苏云金芽孢杆菌基因组为模板扩增出aiiA基因后构建出pPIC9K-aiiA重组表达载体,线性化后转化毕赤酵母GS115,获得重组工程菌GS115/pPIC9K-aiiA,以体积分数为1%的甲醇进行诱导表达.表达产物经SDS-PAGE及Western blotting分析显示表达的蛋白具有较好的免疫特异性.抗病性实验显示表达的目的蛋白具有生物学活性和良好的抗病能力.     

HIV-1C亚型DNA疫苗诱导小鼠免疫反应的研究

 构建含中国流行株HIV-1 C亚型核心蛋白gag基因的重组质粒pVAX-gag,并在体外进行了表达与鉴定.同时构建了含此gag基因的原核表达质粒pGEX-gag,表达纯化并鉴定重组蛋白Gag.以质粒pVAX-gag免疫Balb/C小鼠后,用ELISpot和流式细胞仪检测其细胞免疫反应.再以纯化后的重组蛋白Gag作为包被抗原,用ELISA检测其体液免疫反应.结果显示重组质粒pVAX-gag免疫小鼠后可有效地诱导机体产生细胞免疫和体液免疫反应,且免疫剂量和免疫效果存在一定的正相关性.重组原核表达质粒pGEX-gag的表达产物能与抗p24单克隆抗体发生特异性反应,可用于抗HIV抗体检测.     

汉坦病毒G1S0.7嵌合基因真核载体的构建及表达

构建含汉坦病毒嵌合基因G1S0.7的真核重组质粒,并在真核细胞中有效表达.从本室前期构建并经测序的重组质粒pShuttle-G1S0.7上双酶切回收得到片段G1S0.7后,克隆入真核表达载体pVAX,并将其通过脂质体介导转染HEK293细胞,表达产物用ELISA和Western-blot进行鉴定.酶切鉴定结果表明,成功构建了含汉坦病毒嵌合基因G1S0.7的重组质粒pVAX-G1S0.7; ELISA检测结果和Western-blot结果显示,汉坦病毒G1S0.7嵌合基因在HEK293细胞中得到了表达,所表达的融合蛋白分子量约90kD,与预期大小一致,并且表达产物可与抗汉坦病毒NP mAb特异性结合.说明所构建的表达载体可在真核细胞中表达出与汉坦病毒抗体有特异性结合活性的融合蛋白,为下一步基因免疫及进一步筛选HFRS基因疫苗候选组分提供实验依据.     

重组人碱性成纤维细胞生长因子类似物在大肠杆菌中的分泌表达研究

用带有大肠杆菌外膜蛋白信号肽序列的重组分泌型表达载体pSE-hbFGF，在大肠杆菌BL21中分泌表达了rhbFGF类似物。SDS－PAGE、免疫印迹结果表明，表达产物分泌到了细胞周质和培养液中，用间接ELISA测定出培养上清中的rhbFGF类似物为24.5mg/L，周质中为36.5mg/L菌液（O.D600nm=10)。同时探讨了发酵培养中影响rhbFGF表达的几个关键因素，如诱导时期的选择、诱导时间的长短、培养基的选择及诱导剂的浓度等。     

Secretory expression of the fusion protein composed of human IL-2 and PreS antigen of hepatitis B virus in mammalian cells

In order to make entire HBV pmSAg secrete from mammalian cells, we conatmcted an eukaryotic expression vector by using leader sequence of human interleukin-2 (IL-2) as secretory signal peptide, and using high hydmphilic amino acids as the linker between IL-2 C end and preSAg N end. As a result, the IL-2preS fusing protein could be secreted from mamalian cells transfected with the reconstructed vector and the expression efficiency was identical to that of natural IL-2. It was considered that the retentive effect of preSlAg could be successfully bypassed. The results not only laid a theoretical and practical foundation for constructing specific gene vaccine against HBV persistent infection, but also supplied experimental evidence for studying modulation of protein secretory expression.     

分泌型Survivin真核表达载体的构建及其在HeLa细胞中的表达

目的:构建含6个组氨酸标签(His6)的小鼠存活素(Survivin)融合蛋白的真核表达载体,及其在真核细胞中的表达。方法:根据小鼠Survivin序列设计引物,经过RT-PCR克隆Survivin的cDNA并进一步构建分泌型Sur-vivin的真核表达载体,经测序鉴定后在大肠杆菌中扩增在HeLa细胞中表达;以金属离子螯合层析富集,再用免疫印迹法鉴定。结果:克隆到Survivin编码区全长序列,经DNA测序后证明与已报道序列相同。构建氨基端融合小鼠IL-2信号肽,羧基端带有His6标签的Survivin融合蛋白的真核表达载体,在HeLa细胞中转染成功并且表达;细胞上清经HisTrap HP柱层析富集后,进行免疫印迹分析,表明该融合蛋白以分泌型方式在HeLa细胞中表达。结论:成功克隆Survivin的cDNA,并构建其分泌型真核表达载体。     

一种高效、稳定的分泌型原核表达载体的构建及应用

以本室构建的原核表达载体pTO-T7为基础载体，PCR合成ompT引导序列，插入该载体多克隆位点上游，构建了分泌型原核表达载体pTO-OT．将2个外源基因克隆至pTO-OT，2个重组质粒在大肠杆菌中均得以高效表达．表达产量在25％～34％之间．Western blot分析证实了融合蛋白可被大肠杆菌信号肽酶有效地切割。并具有良好的免疫学活性．对重组表达菌株的连续传代实验证实了该表达载体具有良好的表达稳定性，显示了其在基因工程中的应用价值．     

Specific anti-tumor effect induced by attenuated Salmonella typhimurium vaccine expressing extracellular region of vascular endothelial growth factor receptor 2

The purposes of this research were to study the stable expression of exogenous gene encoding therapeutic protein in attenuated Salmonella typhimurium, observe the metabolism of oral gene vaccine carried by attenuated Salmonella typhimurium in BALB/c mouse, and investigate the feasibility of prevention and treatment of tumors by the recombinant bacteria. Recombinant plasmid pcDNA3.1 VEGFR2(n1-7) was transformed into competent attenuated Salmonella typhimurium SL3261 to develop oral DNA vaccine SL3261-pcDNA3.1 VEGFR2(n1-7). To observe whether the exogenous gene can be expressed in the recombinant bacteria, PCR was performed to amplify the CMV promoter of the eukaryotic expression vector as the proof of stable expression of exogenous protein; transmission elec- tron microscopy (TEM) was applied to observe the morphology of the recombinant bacteria to confirm that the exogenous gene has no impact on the growth of the bacteria, and then BALB/c mice were immunized with the gene vaccine. After inoculation of the gene vaccine, the recombinant bacteria SL3261 could be detected in the tissues such as small intestine, colon, liver and spleen. And then, mice in each group were challenged with tumor cells. The results of animal experiment showed that tumor growth of the mice in experimental group was inhibited and survival time of immunized mice was prolonged compared with control groups. A higher lymphocyte infiltration in tumors from animals treated with DNA vaccine was observed. Immunohistochemical analysis of tumor samples revealed an en- hanced accumulation of CD8 cytotoxic T lymphocytes, as well as an increase in CD4 cells in the tumors of animals treated with the oral gene vaccine compared to tumors from control group mice. Ultrastructure of the tumor tissue showed that tumor cells in the samples of the immunized mice were well-differentiated. Our research confirmed that the exogenous gene can be stably expressed in the attenuated Salmonella typhimurium and has no impact on the growth of the recombinant bacteria; the exogenous gene can de delivered to the host by attenuated Salmonella typhimurium to produce anti-tumor effect with no obvious cytotoxity to the host. In this study, it is established that attenuated Salmonella typhimurium could be used as a vector for oral gene vaccine, and our study provided a theoretical basis for the body distribution and the metabolism of the recombinant bacteria. This strategy may provide a simple, safe and effective way for the prevention and treatment of tumors.     

淋巴囊肿病病毒主要衣壳蛋白1.3 kb基因片段的原核表达

取淋巴囊肿病病毒感染牙鲆组织,蛋白酶K裂解,PCR法成功获得了淋巴囊肿病病毒主要衣壳蛋白1.3 kb基因片段.构建其原核表达载体,IPTG诱导表达.结果表明,该融合蛋白分子量约70 kD,可与抗LCDV多克隆血清特异反应.为LCDV基因工程疫苗的研制奠定了实验基础.